Insider Transactions
Form 4 buys & sells for tracked tickers, same-day tranches collapsed, newest first, each with a conviction & rarity score (hover a score for how it's built; click Score to rank by it) · buyouts & sponsor stakes flagged Control / M&A, after each day's scored trades and below them when ranked by score · last 90 days · showing 3,301–3,600 of 20,314 events matching · excludes filings pending amendment review
More filters
Since: for sales a falling price is shown green (good timing for the seller); sorting uses the raw % change for both.
All transaction types, newest first: each day's buys & sales by score, then grants, exercises and withholdings · buys & sales only
| Score | Ticker | Insider | Role | Transaction | Shares | Price | Value | Sincevs SPY | Date ▼ | 10b5-1 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | COST |
MILLERCHIP GARY
Common Stock
|
Executive Vice President | F Shares withheld for tax 3 lines combined | 1,630.74 | $1,018.21 wtd avg | $1.66M | — | 2026-10-22 | |
| — | COST |
MILLERCHIP GARY
Common Stock
|
Executive Vice President | A Grant / award | 6,140 | — | — | — | 2026-10-22 | |
| — | CART |
Fong Morgan
Stock Option (Right to Buy)
|
Chief Legal Officer | M Option exercise | 18,390 | — | — | — | 2026-10-22 | |
| — | CART |
Fong Morgan
Common Stock
|
Chief Legal Officer | M Option exercise | 18,390 | $7.32 | $135K | — | 2026-10-22 | |
| — | AYI |
Dadyar Sara
Common Stock
|
SVP, Global Head HR | A Grant / award | 1,388 | — | — | — | 2026-10-22 | |
| — | AYI |
GOLDMAN BARRY R
Common Stock
|
SVP & General Counsel | A Grant / award | 1,734 | — | — | — | 2026-10-22 | |
| — | AYI |
HOLCOM KAREN J
Common Stock
|
SVP & Chief Financial Officer | A Grant / award | 2,648 | — | — | — | 2026-10-22 | |
| — | AYI |
ASHE NEIL
Common Stock
|
DirectorPresident & CEO | A Grant / award | 8,078 | — | — | — | 2026-10-22 | |
| — | ANDE |
Hershberger Pamela S
RESTRICTED SHARE UNIT (2026)
|
Director | A Grant / award | 10.42 | — | — | — | 2026-10-22 | |
| — | ANDE |
Hershberger Pamela S
RESTRICTED SHARE UNIT (2025)
|
Director | A Grant / award | 7.21 | — | — | — | 2026-10-22 | |
| — | ANDE |
Hershberger Pamela S
RESTRICTED SHARE UNIT (2024)
|
Director | A Grant / award | 9.84 | — | — | — | 2026-10-22 | |
| — | ANDE |
Douglas Gary A.
RESTRICTED SHARE UNIT (2025)
|
Director | A Grant / award | 7.21 | — | — | — | 2026-10-22 | |
| — | ANDE |
Douglas Gary A.
RESTRICTED SHARE UNIT (2024)
|
Director | A Grant / award | 9.84 | — | — | — | 2026-10-22 | |
| — | ANDE |
Douglas Gary A.
Common Stock
|
Director | J Other (see footnote) | 38.29 | $65.15 | $2K | — | 2026-10-22 | |
| — | VZ |
SCHULMAN DANIEL H
Phantom Stock (unitized)
|
DirectorCEO | A Grant / award | 206.16 | $12.91 | $3K | — | 2026-10-22 | |
| — | VZ |
Malady Kyle
Phantom Stock (unitized)
|
EVP and Group CEO-VZ Business | A Grant / award | 134.66 | $12.91 | $2K | — | 2026-10-22 | |
| — | VZ |
Russo Joseph J.
Phantom Stock (unitized)
|
EVP&Pres-Global Networks&Tech | A Grant / award | 85.50 | $12.91 | $1K | — | 2026-10-22 | |
| — | VZ |
Skiadas Anthony T
Phantom Stock (unitized)
|
EVP and CFO | A Grant / award | 134.66 | $12.91 | $2K | — | 2026-10-22 | |
| — | VZ |
Stillwell Mary-Lee
Phantom Stock (unitized)
|
SVP and Controller | A Grant / award | 45.28 | $12.91 | $585 | — | 2026-10-22 | |
| — | VZ |
Venkatesh Vandana
Phantom Stock (unitized)
|
EVP and Chief Legal Officer | A Grant / award | 98.91 | $12.91 | $1K | — | 2026-10-22 | |
| — | VZ |
Villanueva Rodriguez Alfonso
Phantom Stock (unitized)
|
EVP and Group CEO-VZ Consumer | A Grant / award | 134.66 | $12.91 | $2K | — | 2026-10-22 | |
| — | UTHR |
ROTHBLATT MARTINE A
Stock Option
|
DirectorChairperson & CEO | M Option exercise | 9,500 | — | — | — | 2026-10-22 | |
| — | UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | M Option exercise | 9,500 | $117.76 | $1.12M | — | 2026-10-22 | |
| — | TRV |
Klenk Jeffrey P.
Stock Options (Right to Buy)
|
EVP & Pres., Bond & Spec. Ins. | M Option exercise | 9,016 | — | — | — | 2026-10-22 | |
| — | TRV |
Klenk Jeffrey P.
Common Stock
|
EVP & Pres., Bond & Spec. Ins. | M Option exercise | 9,016 | $132.58 | $1.20M | — | 2026-10-22 | |
| — | TRV |
Rowland David Donnay
Stock Options (Right to Buy)
|
EVP & Co-Chief Invest. Officer | M Option exercise | 5,000 | — | — | — | 2026-10-22 | |
| — | TRV |
Rowland David Donnay
Common Stock
|
EVP & Co-Chief Invest. Officer | M Option exercise | 5,000 | $132.58 | $663K | — | 2026-10-22 | |
| — | TRV |
Toczydlowski Gregory C
Stock Options (Right to Buy)
|
EVP & President, Business Ins. | M Option exercise | 34,771 | — | — | — | 2026-10-22 | |
| — | TRV |
Toczydlowski Gregory C
Common Stock
|
EVP & President, Business Ins. | M Option exercise | 34,771 | $140.85 | $4.90M | — | 2026-10-22 | |
| — | NEE |
Lemasney Mark
Common Stock
|
EVP Power Generation Division | A Grant / award | 1,416 | — | — | — | 2026-10-22 | |
| — | JBHT |
HUNT JOHNNIE B JR
Common Stock
|
Director | G Gift | 4,538 | — | — | — | 2026-10-22 | |
| — | INTU |
SZKUTAK THOMAS J
Restricted Stock Units
|
Director | M Option exercise | 43 | $590.80 | $25K | — | 2026-10-22 | |
| — | INTU |
SZKUTAK THOMAS J
Common Stock
|
Director | M Option exercise | 43 | — | — | — | 2026-10-22 | |
| — | INTU |
DALZELL RICHARD L
Restricted Stock Units
|
Director | M Option exercise | 52 | $590.80 | $31K | — | 2026-10-22 | |
| — | INTU |
DALZELL RICHARD L
Common Stock
|
Director | M Option exercise | 52 | — | — | — | 2026-10-22 | |
| — | CRM |
Harris Parker
Restricted Stock Units
|
DirectorCo-Founder | M Option exercise | 1,785 | — | — | — | 2026-10-22 | |
| — | CRM |
Harris Parker
Common Stock
|
DirectorCo-Founder | F Shares withheld for tax | 886 | $250.29 | $222K | — | 2026-10-22 | |
| — | CRM |
Harris Parker
Common Stock
|
DirectorCo-Founder | M Option exercise | 1,785 | — | — | — | 2026-10-22 | |
| — | AZTA |
Madaus Martin D
Common
|
Interim CEO | F Shares withheld for tax | 1,294 | $36.01 | $47K | — | 2026-10-22 | |
| — | AGIO |
Gheuens Sarah
Stock options (right to buy)
|
Chief Medical Officer | M Option exercise | 500 | — | — | — | 2026-10-22 | |
| — | AGIO |
Gheuens Sarah
Common stock
|
Chief Medical Officer | M Option exercise | 500 | $25.01 | $13K | — | 2026-10-22 | |
| — | RGA |
TRAN KHANH T
Phantom Stock
|
Director | D Sale to issuer | 27 | — | — | — | 2026-10-22 | |
|
29
Unscheduled sale+5
Sale in top 5% of insider-sale size+12
CEO/CFO sale+8
7 insiders selling within 30d+4
Routine29
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
TRV |
Schnitzer Alan D
Common Stock
|
DirectorChairman and CEO | S Sale 5 lines combined | 88,900 | $396.77 wtd avg | $35.3M |
Since sale
$394.99 — -0.4% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
13
Unscheduled sale+5
CEO/CFO sale+8
Routine13
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PEP |
Laguarta Ramon
PepsiCo, Inc. Common Stock
|
DirectorChairman and CEO | S Sale | 30,000 | $135.13 | $4.05M |
Since sale
$141.34 — +4.6% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
13
Unscheduled sale+5
Officer sale+4
7 insiders selling within 30d+4
Routine13
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
TRV |
OLIVO MARIA
Common Stock
|
EVP, ERM & Chief Risk Officer | S Sale | 15,100 | $398.44 wtd avg | $6.02M |
Since sale
$394.99 — -0.9% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
12
CEO/CFO sale+8
4 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ZM |
Chang Michelle
Class A Common Stock
|
Chief Financial Officer | S Sale | 10,156 | $101.93 | $1.04M |
Since sale
$89.88 — -11.8% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-07-08 |
|
12
CEO/CFO sale+8
5 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRWD |
Kurtz George
Class A common stock
|
DirectorPRESIDENT AND CEO | S Sale 13 lines combined | 10,000 | $237.31 wtd avg | $2.37M |
Since sale
$216.89 — -8.6% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-01-16 |
|
12
CEO/CFO sale+8
4 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRCL |
Fox-Geen Jeremy
Class A Common Stock
|
Chief Financial Officer | S Sale | 15,000 | $90.00 | $1.35M |
Since sale
$67.88 — -24.6% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
9
Unscheduled sale+5
Officer sale+4
Routine9
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HPE |
rahim rami
Common Stock
|
EVP, Pres GM Networking | S Sale 2 lines combined | 34,443 | $58.04 wtd avg | $2.00M |
Since sale
$44.77 — -22.9% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
9
Unscheduled sale+5
Officer sale+4
Routine9
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SNX |
POLK DENNIS
Common Stock
|
DirectorChair, Hyve Solutions | S Sale | 3,955 | $251.27 wtd avg | $994K |
Since sale
$218.73 — -13.0% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
9
Unscheduled sale+5
Officer sale+4
Routine9
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ALLY |
Patterson Kathleen L.
Common Stock
|
Chief HR & Corp Citizenship | S Sale | 12,831 | $38.65 wtd avg | $496K |
Since sale
$38.17 — -1.2% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
YELP |
Schwarzbach David A
Common Stock
|
Chief Financial Officer | S Sale | 7,500 | $20.00 | $150K |
Since sale
$19.46 — -2.7% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-05-22 |
|
8
Officer sale+4
3 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SE |
Wang Yanjun
Class A ordinary shares
|
CCO and GC | S Sale 4 lines combined | 800 | $77.64 wtd avg | $62K |
Since sale
$75.73 — -2.5% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
KOD |
BORGESON JOHN A.
Common Stock
|
Chief Financial Officer | S Sale 8 lines combined | 30,000 | $90.01 wtd avg | $2.70M |
Since sale
$99.30 — +10.3% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2025-09-29 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | S Sale 14 lines combined | 9,500 | $560.07 wtd avg | $5.32M |
Since sale
$562.02 — +0.3% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2025-11-07 |
|
5
Unscheduled sale+5
Routine5
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HSY |
HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL
Common Stock, $1.00 par value
|
10% owner | S Sale 3 lines combined | 10,000 | $168.12 wtd avg | $1.68M |
Since sale
$178.08 — +5.9% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Unscheduled |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ZM |
Subotovsky Santiago
Class A Common Stock
|
Director | S Sale 2 lines combined | 3,812 | $100.56 wtd avg | $383K |
Since sale
$89.88 — -10.6% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-01-13 |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ZM |
McMaster Herbert Raymond
Class A Common Stock
|
Director | S Sale | 1,500 | $101.25 | $152K |
Since sale
$89.88 — -11.2% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SNOW |
Dageville Benoit
Common Stock
|
Director | S Sale | 50,000 | $321.74 | $16.1M |
Since sale
$276.34 — -14.1% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-04-03 |
|
4
3 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SMTC |
Walsh Paul V Jr
Common Stock
|
Director | S Sale | 500 | $139.44 | $70K |
Since sale
$103.21 — -26.0% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
4
6 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
NTRA |
Sheena Jonathan
Common Stock
|
DirectorCO-FOUNDER | S Sale 8 lines combined | 3,150 | $410.55 wtd avg | $1.29M |
Since sale
$310.67 — -24.3% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2025-12-12 |
|
4
3 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HOOD |
Bhatt Baiju
Class A Common Stock
|
Director | S Sale 4 lines combined | 50,912 | $101.40 wtd avg | $5.16M |
Since sale
$80.91 — -20.2% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRL |
Parisotto Shannon M
Common Stock
|
CEVP, Disc & Safety Assessment | S Sale | 2,156 | $344.41 | $743K |
Since sale
$337.52 — -2.0% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-03-04 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
AGIO |
Gheuens Sarah
Common stock
|
Chief Medical Officer | S Sale | 1,489 | $37.53 wtd avg | $56K |
Since sale
$29.47 — -21.5% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan date not disclosed |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
WDC |
Tregillis Cynthia L
Common Stock
|
Chief Legal Officer & Corp Sec | S Sale | 807 | $380.00 | $307K |
Since sale
$263.80 — -30.6% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-03-06 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PRGS |
Jarrett Loren
Common Stock
|
EVP/GM Digital Experience | S Sale | 2,086 | $43.47 wtd avg | $91K |
Since sale
$43.50 — +0.1% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-01-24 |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PINS |
Silbermann Benjamin
Class A Common Stock
|
Director10% owner | S Sale | 46,875 | $22.94 wtd avg | $1.08M |
Since sale
$18.96 — -17.4% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-02-27 |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PINS |
Rajaram Gokul
Class A Common Stock
|
Director | S Sale | 1,050 | $22.84 | $24K |
Since sale
$18.96 — -17.0% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2025-11-25 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PCTY |
Sarowitz Steven I
Common Stock, par value $0.001
|
Director10% owner | S Sale 4 lines combined | 5,744 | $170.28 wtd avg | $978K |
Since sale
$173.15 — +1.7% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2025-12-15 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
XYZ |
Eisen Anthony Mathew
Class A Common Stock
|
Director | S Sale | 6,000 | $79.07 | $474K |
Since sale
$85.48 — +8.1% ▲
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-03-02 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
TER |
MATZ MARILYN
Common Stock
|
Director | S Sale | 400 | $350.00 | $140K |
Since sale
$218.22 — -37.7% ▼
vs SPY -1.6%
16 days held · as of Nov 6
|
2026-10-21 | Scheduled plan adopted 2026-02-13 |
| — | TRV |
Schnitzer Alan D
Stock Options (Right to Buy)
|
DirectorChairman and CEO | M Option exercise | 298,368 | — | — | — | 2026-10-21 | |
| — | TRV |
Schnitzer Alan D
Common Stock
|
DirectorChairman and CEO | F Shares withheld for tax | 209,468 | $397.62 | $83.3M | — | 2026-10-21 | |
| — | TRV |
Schnitzer Alan D
Common Stock
|
DirectorChairman and CEO | M Option exercise | 298,368 | $132.58 | $39.6M | — | 2026-10-21 | |
| — | SNOW |
Dageville Benoit
Common Stock
|
Director | G Gift | 16,668 | — | — | — | 2026-10-21 | |
| — | SE |
Feng Zhimin
Share options (right to buy)
|
President | X Option exercise | 1,000,000 | — | — | — | 2026-10-21 | |
| — | SE |
Feng Zhimin
Class A ordinary shares
|
President | X Option exercise | 1,000,000 | $15.00 | $15.0M | — | 2026-10-21 | |
| — | MTSI |
Daly Stephen G
Common Stock
|
DirectorPresident and CEO | A Grant / award | 5,941 | — | — | — | 2026-10-21 | |
| — | MTSI |
Kober John
Common Stock
|
Senior VP and CFO | A Grant / award | 2,277 | — | — | — | 2026-10-21 | |
| — | MTSI |
Roth Ambra R.
Common Stock
|
SVP, GC and Secretary | A Grant / award | 1,401 | — | — | — | 2026-10-21 | |
| — | MTSI |
Hwang Donghyun Thomas
Common Stock
|
SVP, Global Sales | A Grant / award | 1,439 | — | — | — | 2026-10-21 | |
| — | MTSI |
Dennehy Robert
Common Stock
|
Senior VP and COO | A Grant / award | 2,104 | — | — | — | 2026-10-21 | |
| — | MEDP |
BURWIG SUSAN E
Employee Stock Option (Right to Buy)
|
Exec. VP, Operations | M Option exercise | 2,700 | — | — | — | 2026-10-21 | |
| — | MEDP |
BURWIG SUSAN E
Common Stock
|
Exec. VP, Operations | M Option exercise | 2,700 | $166.73 | $450K | — | 2026-10-21 | |
| — | MAT |
Matheson Lee
Restricted Stock Units
|
Director | A Grant / award | 6,883 | — | — | — | 2026-10-21 | |
| — | KOD |
BORGESON JOHN A.
Stock Option (Right to Buy)
|
Chief Financial Officer | M Option exercise | 30,000 | — | — | — | 2026-10-21 | |
| — | KOD |
BORGESON JOHN A.
Common Stock
|
Chief Financial Officer | M Option exercise | 30,000 | $2.49 | $75K | — | 2026-10-21 | |
| — | HOOD |
Bhatt Baiju
Class B Common Stock
|
Director | C Conversion of derivative | 50,912 | — | — | — | 2026-10-21 | |
| — | HOOD |
Bhatt Baiju
Class A Common Stock
|
Director | C Conversion of derivative | 50,912 | — | — | — | 2026-10-21 | |
| — | FRPT |
Baty Nicola J.
Common Stock
|
President & COO | A Grant / award | 58,245 | — | — | — | 2026-10-21 | |
| — | DGX |
DELANEY MARK E
Common Stock
|
SVP & Chief Commercial Officer | L Small acquisition | 25 | $235.94 | $6K | — | 2026-10-21 | |
| — | DGX |
MAIN TIMOTHY L
Common Stock
|
Director | L Small acquisition | 18 | $235.94 | $4K | — | 2026-10-21 | |
| — | DGX |
Plewman Patrick
Common Stock
|
SVP for Diagnostic Services | L Small acquisition | 41 | $235.94 | $10K | — | 2026-10-21 | |
| — | DGX |
Lassiter Wright III
Common Stock
|
Director | L Small acquisition | 6 | $235.96 | $1K | — | 2026-10-21 | |
| — | DGX |
KUPPUSAMY KARTHIK
Common Stock
|
SVP, Clinical Solutions | L Small acquisition | 33 | $235.94 | $8K | — | 2026-10-21 | |
| — | DGX |
Gregg Vicky B
Common Stock
|
Director | A Grant / award | 63 | $235.94 | $15K | — | 2026-10-21 | |
| — | DGX |
SAMAD SAM
Common Stock
|
Executive Vice President & CFO | A Grant / award | 90 | $235.94 | $21K | — | 2026-10-21 | |
| — | DGX |
CARTER ROBERT B
Common Stock
|
Director | L Small acquisition | 10 | $235.93 | $2K | — | 2026-10-21 | |
| — | CRL |
Parisotto Shannon M
Stock Options (Right to Buy)
|
CEVP, Disc & Safety Assessment | M Option exercise | 2,156 | — | — | — | 2026-10-21 | |
| — | CRL |
Parisotto Shannon M
Common Stock
|
CEVP, Disc & Safety Assessment | M Option exercise | 2,156 | $244.41 | $527K | — | 2026-10-21 | |
| — | CRCL |
Fox-Geen Jeremy
Stock Option (Right to Buy)
|
Chief Financial Officer | M Option exercise | 15,000 | — | — | — | 2026-10-21 | |
| — | CRCL |
Fox-Geen Jeremy
Class A Common Stock
|
Chief Financial Officer | M Option exercise | 15,000 | $10.11 | $152K | — | 2026-10-21 | |
| — | BAC |
Fitterling James R
Phantom Stock
|
Director | A Grant / award | 2,930.68 | — | — | — | 2026-10-21 | |
| — | BAC |
Thomas William B.
Common Stock
|
Director | F Shares withheld for tax | 1,170 | $50.78 | $59K | — | 2026-10-21 | |
| — | BAC |
Thomas William B.
Common Stock
|
Director | A Grant / award | 2,930 | — | — | — | 2026-10-21 | |
| — | AGIO |
Gheuens Sarah
Stock options (right to buy)
|
Chief Medical Officer | M Option exercise | 1,489 | — | — | — | 2026-10-21 | |
| — | AGIO |
Gheuens Sarah
Common stock
|
Chief Medical Officer | M Option exercise | 1,489 | $25.01 | $37K | — | 2026-10-21 | |
| — | ADC |
AGREE RICHARD
Common Shares
|
DirectorEXECUTIVE CHAIRMAN OF BOARD | G Gift | 4,025 | — | — | — | 2026-10-21 | |
| — | ADC |
Agree Joey
Common Shares
|
DirectorPRESIDENT & CEO | G Gift 2 lines combined | 2,300 | — | — | — | 2026-10-21 | |
| — | UTHR |
ROTHBLATT MARTINE A
Stock Option
|
DirectorChairperson & CEO | M Option exercise | 9,500 | — | — | — | 2026-10-21 | |
| — | UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | M Option exercise | 9,500 | $117.76 | $1.12M | — | 2026-10-21 | |
| — | SNX |
POLK DENNIS
Employee Stock Option (Right to Buy)
|
DirectorChair, Hyve Solutions | M Option exercise | 2,905 | — | — | — | 2026-10-21 | |
| — | SNX |
POLK DENNIS
Stock Option (Right to Buy)
|
DirectorChair, Hyve Solutions | M Option exercise | 1,050 | — | — | — | 2026-10-21 | |
| — | SNX |
POLK DENNIS
Common Stock
|
DirectorChair, Hyve Solutions | M Option exercise 2 lines combined | 3,955 | $107.06 wtd avg | $423K | — | 2026-10-21 | |
| — | KTB |
Caulfield James T.
Common Stock
|
Director | A Grant / award | 1,792 | — | — | — | 2026-10-21 | |
| — | GH |
MIGNONE ROBERTO
Restricted Stock Units
|
Director | M Option exercise | 264 | — | — | — | 2026-10-21 | |
| — | GH |
MIGNONE ROBERTO
Common Stock
|
Director | M Option exercise | 264 | — | — | — | 2026-10-21 | |
| — | ESE |
Abson Jeremy
Restricted Share Units
|
Director | A Grant / award | 167 | $269.92 | $45K | — | 2026-10-21 | |
| — | COHR |
Beard Robert P
Common Stock
|
Chief Strategy & Legal Officer | F Shares withheld for tax | 5,127 | $231.80 | $1.19M | — | 2026-10-21 | |
| — | XYL |
Emmerich Meredith
Common Stock
|
EVP & President, MCS | F Shares withheld for tax | 837 | $106.35 | $89K | — | 2026-10-21 | |
| — | PINS |
Silbermann Benjamin
Class B Common Stock
|
Director10% owner | C Conversion of derivative | 46,875 | — | — | — | 2026-10-21 | |
| — | PINS |
Silbermann Benjamin
Class A Common Stock
|
Director10% owner | C Conversion of derivative | 46,875 | — | — | — | 2026-10-21 | |
| — | AIG |
Walsh Keith
Common Stock
|
EVP and CFO | F Shares withheld for tax | 688 | $81.75 | $56K | — | 2026-10-21 | |
|
63
Open-market purchase+25
Unscheduled+15
Purchase $1.5M (p75–p90)+12
Director+7
First purchase in our history+4
Elevated63
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
FBK |
INGRAM ORRIN H II
Common Stock
|
Director | P Purchase 2 lines combined | 29,081 | $52.88 wtd avg | $1.54M |
Since buy
$54.17 — +2.4% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
47
Open-market purchase+25
Unscheduled+15
Director+7
Some signal47
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
AMT |
Clarke Teresa Hillary
Common Stock
|
Director | P Purchase | 42.93 | $183.20 | $8K |
Since buy
$188.79 — +3.1% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
13
Unscheduled sale+5
Officer sale+4
7 insiders selling within 30d+4
Routine13
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
TRV |
Klein Michael Frederick
Common Stock
|
EVP & President, Personal Ins. | S Sale 2 lines combined | 7,500 | $392.79 wtd avg | $2.95M |
Since sale
$394.99 — +0.6% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
13
Unscheduled sale+5
CEO/CFO sale+8
Routine13
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
VRSN |
BIDZOS D JAMES
Common Stock
|
DirectorExec. Chairman, Pres, & CEO | S Sale 4 lines combined | 3,300 | $306.30 wtd avg | $1.01M |
Since sale
$308.67 — +0.8% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
12
CEO/CFO sale+8
5 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRWD |
Kurtz George
Class A common stock
|
DirectorPRESIDENT AND CEO | S Sale 7 lines combined | 10,000 | $226.71 wtd avg | $2.27M |
Since sale
$216.89 — -4.3% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-01-16 |
|
12
CEO/CFO sale+8
4 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ADI |
Puccio Richard C Jr
Comm Stock - $.16-2/3 value
|
Chief Financial Officer | S Sale | 1,500 | $389.46 | $584K |
Since sale
$363.26 — -6.7% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-05-21 |
|
12
CEO/CFO sale+8
4 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
QCOM |
Palkhiwala Akash J.
Common Stock
|
EVP, CFO & COO | S Sale 6 lines combined | 2,500 | $175.06 wtd avg | $438K |
Since sale
$165.20 — -5.6% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-12-08 |
|
9
Unscheduled sale+5
Officer sale+4
Routine9
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CYTK |
Malik Fady Ibraham
Common Stock
|
EVP Research & Development | S Sale | 3,500 | $64.01 | $224K |
Since sale
$53.69 — -16.1% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
8
Officer sale+4
3 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
W |
Tan Fiona
Class A Common Stock
|
Chief Technology Officer | S Sale | 8,000 | $115.00 | $920K |
Since sale
$111.74 — -2.8% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
VSAT |
Chase Garrett L.
$.0001 par value common stock
|
SVP, Chief Financial Officer | S Sale 2 lines combined | 4,000 | $58.86 wtd avg | $235K |
Since sale
$63.95 — +8.7% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-02-25 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
STT |
O HANLEY RONALD P
Common Stock
|
DirectorChairman, CEO and President | S Sale | 14,554 | $164.60 | $2.40M |
Since sale
$165.56 — +0.6% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-11-26 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SBUX |
BREWER BRADY
Common Stock
|
ceo, International | S Sale | 588 | $100.00 | $59K |
Since sale
$105.41 — +5.4% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-12-03 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ROIV |
Venker Eric
Common Shares
|
President & Immunovant CEO | S Sale 2 lines combined | 200,000 | $35.11 wtd avg | $7.02M |
Since sale
$38.88 — +10.7% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-06-30 |
|
8
Officer sale+4
5 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRDO |
Cheng Chi Fung
Ordinary Shares
|
DirectorChief Technology Officer | S Sale 14 lines combined | 27,500 | $172.62 wtd avg | $4.75M |
Since sale
$120.04 — -30.5% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
8
Officer sale+4
4 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
ANET |
Duda Kenneth
Common Stock
|
DirectorPresident and CTO | S Sale 18 lines combined | 43,333 | $180.91 wtd avg | $7.84M |
Since sale
$170.80 — -5.6% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
8
Officer sale+4
5 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
AAPL |
Newstead Jennifer
Common Stock
|
SVP, GC and Government Affairs | S Sale | 2,399 | $339.62 | $815K |
Since sale
$342.39 — +0.8% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-05-05 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
VZ |
Malady Kyle
Common Stock
|
EVP and Group CEO-VZ Business | S Sale | 1,100 | $44.48 | $49K |
Since sale
$45.69 — +2.7% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-05-18 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | S Sale 17 lines combined | 9,500 | $553.87 wtd avg | $5.26M |
Since sale
$562.02 — +1.5% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-11-07 |
|
8
Officer sale+4
3 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SE |
Wang Yanjun
Class A ordinary shares
|
CCO and GC | S Sale 6 lines combined | 800 | $81.61 wtd avg | $65K |
Since sale
$75.73 — -7.2% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CHH |
Dragisich Dominic
Common Stock
|
DirectorPresident & CEO | S Sale | 1,227 | $112.00 | $137K |
Since sale
$118.91 — +6.2% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-02-24 |
|
5
Unscheduled sale+5
Routine5
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PAGS |
Magnani Alexandre Mr
Class A Common Shares
|
Director | S Sale | 47,100 | $11.22 wtd avg | $528K |
Since sale
$7.60 — -32.2% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
5
Unscheduled sale+5
Routine5
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HSY |
HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL
Common Stock, $1.00 par value
|
10% owner | S Sale 2 lines combined | 10,000 | $168.85 wtd avg | $1.69M |
Since sale
$178.08 — +5.5% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Unscheduled |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SOFI |
Keough Kelli
Common Stock
|
EVP, GBUL, SIPS | S Sale | 10,203 | $14.72 wtd avg | $150K |
Since sale
$16.21 — +10.1% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-07-30 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PTON |
Baig Saqib
Class A Common Stock
|
Chief Accounting Officer | S Sale | 10,000 | $5.45 | $54K |
Since sale
$5.61 — +2.9% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-09-02 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
NDAQ |
SKULE JEREMY
Common Stock, par value $0.01 per share
|
EVP, CSO | S Sale | 1,125 | $95.00 | $107K |
Since sale
$107.15 — +12.8% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-05-07 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
JBL |
Schick Gary K.
Common Stock
|
SVP, CHRO | S Sale 6 lines combined | 1,000 | $277.16 wtd avg | $277K |
Since sale
$239.09 — -13.7% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-03-21 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
INTA |
Harrison David Benjamin
Common Stock
|
President, Industries | S Sale | 40,284 | $45.26 wtd avg | $1.82M |
Since sale
$43.72 — -3.4% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
BROS |
Boersma Travis
Class A Common Stock
|
DirectorExecutive Chairman of Board10% owner | S Sale 2 lines combined | 145,687 | $44.01 wtd avg | $6.41M |
Since sale
$33.77 — -23.3% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SYNA |
Patel Rahul G.
Common Stock
|
DirectorSee remarks below | S Sale | 4,302 | $117.55 wtd avg | $506K |
Since sale
$116.70 — -0.7% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SNX |
Thompson Reyna
Common Stock
|
President, North America | S Sale 6 lines combined | 2,433 | $248.45 wtd avg | $604K |
Since sale
$218.73 — -12.0% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-01-28 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
QLYS |
POSEY BRUCE K
Common Stock
|
CHIEF LEGAL OFFICER | S Sale 6 lines combined | 881 | $189.52 wtd avg | $167K |
Since sale
$190.41 — +0.5% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-08-21 |
|
4
4 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PINS |
Silbermann Benjamin
Class A Common Stock
|
Director10% owner | S Sale | 46,875 | $22.56 wtd avg | $1.06M |
Since sale
$18.96 — -16.0% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-02-27 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CVX |
Pate R. Hewitt
Common Stock
|
Chief Legal Officer | S Sale | 40,700 | $226.65 | $9.22M |
Since sale
$212.65 — -6.2% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-11-26 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRUS |
Baumgartner Jeffrey W
Common Stock
|
EVP, R&D | S Sale | 1,166 | $107.75 | $126K |
Since sale
$113.58 — +5.4% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-02-27 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
GWRE |
Mullen John P
Common Stock
|
President | S Sale | 5,400 | $185.00 | $999K |
Since sale
$161.41 — -12.8% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-10-14 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
XYZ |
Eisen Anthony Mathew
Class A Common Stock
|
Director | S Sale | 6,000 | $77.25 | $464K |
Since sale
$85.48 — +10.7% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-03-02 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PCTY |
Sarowitz Steven I
Common Stock, par value $0.001
|
Director10% owner | S Sale 4 lines combined | 10,617 | $169.76 wtd avg | $1.80M |
Since sale
$173.15 — +2.0% ▲
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2025-12-15 |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
MNDY |
Eyal Aviad
Ordinary Shares
|
Director | S Sale | 2,000 | $100.04 wtd avg | $200K |
Since sale
$87.93 — -12.1% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
BROS |
DM Trust Aggregator, LLC
Class A Common Stock
|
10% owner | S Sale | 94,978 | $44.01 wtd avg | $4.18M |
Since sale
$33.77 — -23.3% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
BROS |
DM Individual Aggregator, LLC
Class A Common Stock
|
10% owner | S Sale | 50,709 | $44.01 wtd avg | $2.23M |
Since sale
$33.77 — -23.3% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan date not disclosed |
|
0
Routine0
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HUBS |
Halligan Brian
Common Stock
|
Director | S Sale | 8,500 | $239.57 | $2.04M |
Since sale
$200.61 — -16.3% ▼
vs SPY -1.1%
17 days held · as of Nov 6
|
2026-10-20 | Scheduled plan adopted 2026-03-12 |
| — | WTW |
Clarke Lucy
Ordinary Shares, nominal value $0.000304635 per share
|
President of Risk & Broking | F Shares withheld for tax | 6 | $288.23 | $2K | — | 2026-10-20 | |
| — | WDC |
Tregillis Cynthia L
Dividend Equivalent Rights
|
Chief Legal Officer & Corp Sec | M Option exercise | 14.37 | — | — | — | 2026-10-20 | |
| — | WDC |
Tregillis Cynthia L
Common Stock
|
Chief Legal Officer & Corp Sec | F Shares withheld for tax | 1,309.71 | $364.32 | $477K | — | 2026-10-20 | |
| — | WDC |
Tregillis Cynthia L
Common Stock
|
Chief Legal Officer & Corp Sec | M Option exercise | 14.37 | — | — | — | 2026-10-20 | |
| — | VRTX |
Brennan Daniel J.
Common Stock
|
Director | A Grant / award | 795 | $503.47 | $400K | — | 2026-10-20 | |
| — | VMI |
Johnson William Eric
Common Stock
|
Chief Accounting Officer | F Shares withheld for tax | 74 | $450.68 | $33K | — | 2026-10-20 | |
| — | VLTO |
Honeycutt Jennifer
Common Stock
|
DirectorPresident and CEO | F Shares withheld for tax 2 lines combined | 4,025 | $94.68 wtd avg | $381K | — | 2026-10-20 | |
| — | TRV |
Klein Michael Frederick
Stock Options (Right to Buy)
|
EVP & President, Personal Ins. | M Option exercise | 7,500 | — | — | — | 2026-10-20 | |
| — | TRV |
Klein Michael Frederick
Common Stock
|
EVP & President, Personal Ins. | M Option exercise | 7,500 | $139.83 | $1.05M | — | 2026-10-20 | |
| — | TEX |
Hegarty Kieran
Common Stock, par value $.01
|
President, Materials Processin | F Shares withheld for tax | 7,687 | $50.76 | $390K | — | 2026-10-20 | |
| — | SNDK |
Shek Bernard
Common Stock
|
Chief Legal Officer and Secty | F Shares withheld for tax | 322 | $1,365.38 | $440K | — | 2026-10-20 | |
| — | SHW |
Binns Justin T
Employee Stock Option (Right to Buy)
|
President, Glob. Architectural | A Grant / award | 12,055 | — | — | — | 2026-10-20 | |
| — | SHW |
Boyce Marlena K.
Employee Stock Option (Right to Buy)
|
SVP - CHRO | A Grant / award | 6,220 | — | — | — | 2026-10-20 | |
| — | SHW |
Davie Colin M.
Employee Stock Option (Right to Buy)
|
Pres. & GM, Glob. Supply Chain | A Grant / award | 7,000 | — | — | — | 2026-10-20 | |
| — | SHW |
GARCEAU MARY L
Employee Stock Option (Right to Buy)
|
SVP - CLO and Secretary | A Grant / award | 7,585 | — | — | — | 2026-10-20 | |
| — | SHW |
Jaye James R
Employee Stock Option (Right to Buy)
|
SVP - IR & Corp. Comm. | A Grant / award | 2,335 | — | — | — | 2026-10-20 | |
| — | SHW |
Jorgenrud Karl J
Employee Stock Option (Right to Buy)
|
President, Glob. Industrial | A Grant / award | 12,055 | — | — | — | 2026-10-20 | |
| — | SHW |
Lang James P.
Employee Stock Option (Right to Buy)
|
SVP - Enterprise Finance & CAO | A Grant / award | 2,335 | — | — | — | 2026-10-20 | |
| — | SHW |
Meisenzahl Benjamin E.
Employee Stock Option (Right to Buy)
|
SVP - Finance and CFO | A Grant / award | 13,805 | — | — | — | 2026-10-20 | |
| — | SHW |
Petz Heidi G
Employee Stock Option (Right to Buy)
|
DirectorPresident & CEO | A Grant / award | 47,640 | — | — | — | 2026-10-20 | |
| — | SHW |
Rea Todd D
Employee Stock Option (Right to Buy)
|
President, Consumer Brands Grp | A Grant / award | 4,470 | — | — | — | 2026-10-20 | |
| — | SHW |
Young Bryan J
Employee Stock Option (Right to Buy)
|
SVP - Corp Strategy & Devel. | A Grant / award | 3,500 | — | — | — | 2026-10-20 | |
| — | RIVN |
Krawiec Peter
Class A Common Stock
|
Director | A Grant / award | 928 | — | — | — | 2026-10-20 | |
| — | RIVN |
Krafcik John
Class A Common Stock
|
Director | A Grant / award | 1,251 | — | — | — | 2026-10-20 | |
| — | RIVN |
Schwartz Sanford Harold
Class A Common Stock
|
Director | A Grant / award | 1,251 | — | — | — | 2026-10-20 | |
| — | RIVN |
Gomez Aidan N.
Class A Common Stock
|
Director | F Shares withheld for tax | 420 | $12.34 | $5K | — | 2026-10-20 | |
| — | RIVN |
Gomez Aidan N.
Class A Common Stock
|
Director | A Grant / award | 807 | — | — | — | 2026-10-20 | |
| — | MTCH |
Eigenmann Philip D
Dividend Equivalents
|
Chief Accounting Officer | A Grant / award 3 lines combined | 148 | — | — | — | 2026-10-20 | |
| — | MTCH |
Edgett Sean
Dividend Equivalents
|
Chief Leg. & Corp. Aff. Off. | A Grant / award 3 lines combined | 515 | — | — | — | 2026-10-20 | |
| — | MTCH |
Bronstein Manuel
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Bailey Stephen
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Jones Laura Rachel
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Jones Laura Rachel
Common Stock, par value $0.001
|
Director | A Grant / award | 17 | $46.53 | $791 | — | 2026-10-20 | |
| — | MTCH |
Brenner Melissa Anne
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Schiffman Glenn
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Schiffman Glenn
Common Stock, par value $0.001
|
Director | A Grant / award | 32 | $46.53 | $1K | — | 2026-10-20 | |
| — | MTCH |
Rascoff Spencer M
Dividend Equivalents
|
DirectorChief Executive Officer | A Grant / award 3 lines combined | 5,010 | — | — | — | 2026-10-20 | |
| — | MTCH |
Bailey Steven Richard Jr.
Dividend Equivalents
|
Chief Financial Officer | A Grant / award 3 lines combined | 429 | — | — | — | 2026-10-20 | |
| — | MTCH |
MCDANIEL ANN
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
MCINERNEY THOMAS
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
CAVENS DARRELL
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
CAVENS DARRELL
Common Stock, par value $0.001
|
Director | A Grant / award | 13 | $46.53 | $605 | — | 2026-10-20 | |
| — | MTCH |
MOSKOWITZ RAINA
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | MTCH |
Campbell Kotzman Kelly
Dividend Equivalents
|
Director | A Grant / award | 29 | — | — | — | 2026-10-20 | |
| — | LYFT |
Brous Michael Zachary
Class A Common Stock
|
CHIEF FINANCIAL OFFICER | A Grant / award 3 lines combined | 255,861 | — | — | — | 2026-10-20 | |
| — | LYFT |
Stephenson Dave
Class A Common Stock
|
Director | A Grant / award | 942 | — | — | — | 2026-10-20 | |
| — | LYFT |
Whiteside Janey
Class A Common Stock
|
Director | A Grant / award | 775 | — | — | — | 2026-10-20 | |
| — | ERIE |
Bolash Brian W.
Incentive Compensation Deferral Plan Share Credits
|
EVP,Secretary,General Counsel | J Other (see footnote) | 21.07 | $245.94 | $5K | — | 2026-10-20 | |
| — | ERIE |
Cipriani Marc
Incentive Compensation Deferral Plan Share Credits
|
Senior Vice President | J Other (see footnote) | 13.31 | $245.94 | $3K | — | 2026-10-20 | |
| — | ERIE |
Cook Cody
Incentive Compensation Deferral Plan Share Credits
|
Executive Vice President | J Other (see footnote) | 7.68 | $245.94 | $2K | — | 2026-10-20 | |
| — | ERIE |
Dugan Sean
Incentive Compensation Deferral Plan Share Credits
|
Executive Vice President | J Other (see footnote) | 7.77 | $245.94 | $2K | — | 2026-10-20 | |
| — | ERIE |
NECASTRO TIMOTHY G
Incentive Compensation Deferral Plan Share Credits
|
President & CEO | J Other (see footnote) | 77.34 | $245.93 | $19K | — | 2026-10-20 | |
| — | ERIE |
Novacek Jorie L
Incentive Compensation Deferral Plan Share Credits
|
SVP, Controller | J Other (see footnote) | 5.98 | $245.94 | $1K | — | 2026-10-20 | |
| — | ERIE |
Pelkowski Julie Marie
Incentive Compensation Deferral Plan Share Credits
|
EVP & CFO | J Other (see footnote) | 12.54 | $245.93 | $3K | — | 2026-10-20 | |
| — | ERIE |
Shine Sarah
Incentive Compensation Deferral Plan Share Credits
|
Executive Vice President | J Other (see footnote) | 16.13 | $245.94 | $4K | — | 2026-10-20 | |
| — | ERIE |
Srinivasa Parthasarathy
Incentive Compensation Deferral Plan Share Credits
|
EVP, Chief Information Officer | J Other (see footnote) | 16.34 | $245.94 | $4K | — | 2026-10-20 | |
| — | EPAC |
Sternlieb Paul
Class A Common Stock
|
DirectorPresident and CEO | F Shares withheld for tax | 8,066 | $35.56 | $287K | — | 2026-10-20 | |
| — | CRWV |
HUTCHINS GLENN H
Class A Common Stock
|
Director | A Grant / award | 320 | — | — | — | 2026-10-20 | |
| — | CRWV |
WHITMAN MARGARET C
Class A Common Stock
|
Director | A Grant / award | 122 | — | — | — | 2026-10-20 | |
| — | CHE |
MCNAMARA KEVIN J
Stock Option (right to buy with tandem tax withholding)
|
Directorpresident and CEO | A Grant / award | 36,693 | $512.64 | $18.8M | — | 2026-10-20 | |
| — | CHE |
Witzeman Michael D
Stock Option (right to buy with tandem tax withholding)
|
VP & Chief Financial Officer | A Grant / award | 12,686 | $512.64 | $6.50M | — | 2026-10-20 | |
| — | CHE |
HUTTON THOMAS C
Stock Option (right to buy with tandem tax withholding)
|
Directorvice president | A Grant / award | 3,964 | $512.64 | $2.03M | — | 2026-10-20 | |
| — | CHE |
Judkins Brian C
Stock Option (right to buy with tandem tax withholding)
|
VP and Chief Legal Officer | A Grant / award | 9,392 | $512.64 | $4.81M | — | 2026-10-20 | |
| — | CHE |
LEE SPENCER S
Stock Option (right to buy with tandem tax withholding)
|
executive vice president | A Grant / award | 7,125 | $512.64 | $3.65M | — | 2026-10-20 | |
| — | CHE |
Wherley Joel L
Stock Option (right to buy with tandem tax withholding)
|
CEO - Vitas Healthcare | A Grant / award | 12,686 | $512.64 | $6.50M | — | 2026-10-20 | |
| — | ANET |
Duda Kenneth
Non-Qualified Stock Option (right to buy)
|
DirectorPresident and CTO | M Option exercise | 17,333 | — | — | — | 2026-10-20 | |
| — | ANET |
Duda Kenneth
Common Stock
|
DirectorPresident and CTO | M Option exercise | 17,333 | $14.15 | $245K | — | 2026-10-20 | |
| — | ALLY |
Hall William Cadik Jr.
Common Stock
|
President - Corporate Finance | F Shares withheld for tax | 10,614 | $37.97 | $403K | — | 2026-10-20 | |
| — | ALLY |
Hutchinson Russell E.
Common Stock
|
Chief Financial Officer | F Shares withheld for tax | 21,074 | $37.97 | $800K | — | 2026-10-20 | |
| — | ALLY |
Patterson Kathleen L.
Common Stock
|
Chief HR & Corp Citizenship | F Shares withheld for tax | 31,047 | $37.97 | $1.18M | — | 2026-10-20 | |
| — | ALLY |
Richard Stephanie N
Common Stock
|
Chief Risk Officer | F Shares withheld for tax | 9,032 | $37.97 | $343K | — | 2026-10-20 | |
| — | ALLY |
Timmerman Douglas R.
Common Stock
|
President, DFS | F Shares withheld for tax | 98,329 | $37.97 | $3.73M | — | 2026-10-20 | |
| — | AIT |
Olosky Michael
Common Stock
|
Director | A Grant / award | 110 | — | — | — | 2026-10-20 | |
| — | ACN |
Egawa Atsushi
Class A ordinary shares
|
Co-CEO Asia Pacific | A Grant / award | 3,194 | — | — | — | 2026-10-20 | |
| — | ACN |
Macchi Mauro
Class A ordinary shares
|
Chief Executive Officer-EMEA | F Shares withheld for tax | 1,203 | $240.74 | $290K | — | 2026-10-20 | |
| — | ACN |
Macchi Mauro
Class A ordinary shares
|
Chief Executive Officer-EMEA | A Grant / award | 3,194 | — | — | — | 2026-10-20 | |
| — | ACN |
Walsh John F
Class A ordinary shares
|
CEO-Americas | F Shares withheld for tax | 5,186 | $240.75 | $1.25M | — | 2026-10-20 | |
| — | ACN |
Walsh John F
Class A ordinary shares
|
CEO-Americas | A Grant / award | 10,211 | — | — | — | 2026-10-20 | |
| — | ACN |
Sharma Manish
Class A ordinary shares
|
Strategy/Reinvention Svcs Ofcr | F Shares withheld for tax | 5,647 | $240.75 | $1.36M | — | 2026-10-20 | |
| — | ACN |
Sharma Manish
Class A ordinary shares
|
Strategy/Reinvention Svcs Ofcr | A Grant / award | 10,211 | — | — | — | 2026-10-20 | |
| — | ACN |
Hogan Catherine Kiernan
Class A ordinary shares
|
Chief Operating Officer | F Shares withheld for tax | 645 | $240.75 | $155K | — | 2026-10-20 | |
| — | ACN |
Hogan Catherine Kiernan
Class A ordinary shares
|
Chief Operating Officer | A Grant / award | 1,793 | — | — | — | 2026-10-20 | |
| — | ACN |
Park Angie Y
Class A ordinary shares
|
Chief Financial Officer | F Shares withheld for tax | 358 | $240.75 | $86K | — | 2026-10-20 | |
| — | ACN |
Park Angie Y
Class A ordinary shares
|
Chief Financial Officer | A Grant / award | 793 | — | — | — | 2026-10-20 | |
| — | ACN |
Unruch Joel
Class A ordinary shares
|
General Counsel, Corp Sec, CRO | F Shares withheld for tax | 3,676 | $240.75 | $885K | — | 2026-10-20 | |
| — | ACN |
Unruch Joel
Class A ordinary shares
|
General Counsel, Corp Sec, CRO | A Grant / award | 8,297 | — | — | — | 2026-10-20 | |
| — | ACN |
Burgum Melissa A
Class A ordinary shares
|
Chief Accounting Officer | F Shares withheld for tax | 401 | $240.74 | $97K | — | 2026-10-20 | |
| — | ACN |
Burgum Melissa A
Class A ordinary shares
|
Chief Accounting Officer | A Grant / award | 925 | — | — | — | 2026-10-20 | |
| — | ACN |
Sweet Julie Spellman
Class A ordinary shares
|
DirectorChair and CEO | F Shares withheld for tax | 18,788 | $240.75 | $4.52M | — | 2026-10-20 | |
| — | ACN |
Sweet Julie Spellman
Class A ordinary shares
|
DirectorChair and CEO | A Grant / award | 38,302 | — | — | — | 2026-10-20 | |
| — | ACN |
Sekido Ryoji
Class A ordinary shares
|
Co-CEO Asia Pacific | A Grant / award | 3,194 | — | — | — | 2026-10-20 | |
| — | UTHR |
ROTHBLATT MARTINE A
Stock Option
|
DirectorChairperson & CEO | M Option exercise | 9,500 | — | — | — | 2026-10-20 | |
| — | UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | M Option exercise | 9,500 | $117.76 | $1.12M | — | 2026-10-20 | |
| — | QCOM |
ROGERS ALEXANDER H
Restricted Stock Unit
|
EVP, Pres QTL & Global Affairs | A Grant / award | 18,069 | — | — | — | 2026-10-20 | |
| — | QCOM |
CHAPLIN ANN C
Restricted Stock Unit
|
EVP, GenCounsel&CorpSecretary | A Grant / award | 17,959 | — | — | — | 2026-10-20 | |
| — | QCOM |
AMON CRISTIANO R
Restricted Stock Unit
|
DirectorPresident & CEO | A Grant / award | 65,704 | — | — | — | 2026-10-20 | |
| — | QCOM |
ACHOUR BAAZIZ
Restricted Stock Unit
|
EVP, Chief Technology Officer | A Grant / award | 18,069 | — | — | — | 2026-10-20 | |
| — | QCOM |
ACE HEATHER S
Restricted Stock Unit
|
EVP, Chief HR Officer | A Grant / award | 13,689 | — | — | — | 2026-10-20 | |
| — | QCOM |
Palkhiwala Akash J.
Restricted Stock Unit
|
EVP, CFO & COO | A Grant / award | 25,734 | — | — | — | 2026-10-20 | |
| — | PINS |
Silbermann Benjamin
Class B Common Stock
|
Director10% owner | C Conversion of derivative | 46,875 | — | — | — | 2026-10-20 | |
| — | PINS |
Silbermann Benjamin
Class A Common Stock
|
Director10% owner | C Conversion of derivative | 46,875 | — | — | — | 2026-10-20 | |
| — | PI |
Valdez Arthur L Jr
Restricted Stock Units
|
Director | M Option exercise | 1,220 | — | — | — | 2026-10-20 | |
| — | PI |
Valdez Arthur L Jr
Common Stock
|
Director | M Option exercise | 1,220 | — | — | — | 2026-10-20 | |
| — | NTRS |
Qureshi Rima
Common Stock
|
Director | A Grant / award | 495 | — | — | — | 2026-10-20 | |
| — | MAT |
Griffith Peter H.
Restricted Stock Units
|
DirectorChief Financial Officer | A Grant / award 2 lines combined | 206,003 | — | — | — | 2026-10-20 | |
| — | ERIE |
BORNEMAN J RALPH JR
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 123.81 | $245.94 | $30K | — | 2026-10-20 | |
| — | ERIE |
CONNELL EUGENE C
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 21.70 | $245.94 | $5K | — | 2026-10-20 | |
| — | ERIE |
Correnti Salvatore
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 18.21 | $245.93 | $4K | — | 2026-10-20 | |
| — | ERIE |
Datesh LuAnn
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 26.47 | $245.93 | $7K | — | 2026-10-20 | |
| — | ERIE |
Edwards William David
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 1.56 | $245.94 | $383 | — | 2026-10-20 | |
| — | ERIE |
Hagen Jonathan Hirt
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 103.30 | $245.94 | $25K | — | 2026-10-20 | |
| — | ERIE |
Hagen Thomas B
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 88.14 | $245.94 | $22K | — | 2026-10-20 | |
| — | ERIE |
Vorsheck Elizabeth A
Directors' Deferred Compensation Share Credits
|
Director10% owner | A Grant / award | 88.14 | — | — | — | 2026-10-20 | |
| — | ERIE |
HARTZ CHARLES SCOTT
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 117.16 | $245.94 | $29K | — | 2026-10-20 | |
| — | ERIE |
Hudson Brian Arden Sr.
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 21.70 | $245.94 | $5K | — | 2026-10-20 | |
| — | ERIE |
Palmer Thomas W
Directors' Deferred Compensation Share Credits
|
Director | J Other (see footnote) | 95.66 | $245.94 | $24K | — | 2026-10-20 | |
| — | CVX |
Pate R. Hewitt
Non-Qualified Stock Option (Right to Buy)
|
Chief Legal Officer | M Option exercise | 40,700 | — | — | — | 2026-10-20 | |
| — | CVX |
Pate R. Hewitt
Common Stock
|
Chief Legal Officer | M Option exercise | 40,700 | $132.69 | $5.40M | — | 2026-10-20 | |
| — | CYTK |
Malik Fady Ibraham
Non-Qualified Stock Option (Right to Buy)
|
EVP Research & Development | M Option exercise | 3,500 | — | — | — | 2026-10-20 | |
| — | CYTK |
Malik Fady Ibraham
Common Stock
|
EVP Research & Development | M Option exercise | 3,500 | $7.80 | $27K | — | 2026-10-20 | |
|
24
Sale in top 5% of insider-sale size+12
Sale in top 1% of insider-sale size+8
4 insiders selling within 30d+4
Routine24
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SNOW |
Slootman Frank
Common Stock
|
Director | S Sale 10 lines combined | 300,000 | $316.43 wtd avg | $94.9M |
Since sale
$276.34 — -12.7% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-09-19 |
|
13
Unscheduled sale+5
CEO/CFO sale+8
Routine13
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRSP |
Kulkarni Samarth
Common Shares
|
DirectorChief Executive Officer | S Sale | 47,837 | $49.78 | $2.38M |
Since sale
$50.07 — +0.6% ▲
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Unscheduled |
|
12
CEO/CFO sale+8
3 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SE |
Hou Tianyu
Class A ordinary shares
|
CFO | S Sale 6 lines combined | 10,000 | $89.03 wtd avg | $890K |
Since sale
$75.73 — -14.9% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan date not disclosed |
|
12
CEO/CFO sale+8
5 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRWD |
Kurtz George
Class A common stock
|
DirectorPRESIDENT AND CEO | S Sale 6 lines combined | 10,000 | $229.09 wtd avg | $2.29M |
Since sale
$216.89 — -5.3% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2026-01-16 |
|
12
CEO/CFO sale+8
5 insiders selling within 30d+4
Routine12
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CRDO |
Brennan William Joseph
Ordinary Shares
|
DirectorPres & Chief Executive Officer | S Sale 11 lines combined | 16,666 | $174.87 wtd avg | $2.91M |
Since sale
$120.04 — -31.4% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2026-06-10 |
|
8
Officer sale+4
3 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
SE |
Wang Yanjun
Class A ordinary shares
|
CCO and GC | S Sale 3 lines combined | 1,000 | $90.37 wtd avg | $90K |
Since sale
$75.73 — -16.2% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan date not disclosed |
|
8
Officer sale+4
4 insiders selling within 30d+4
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
META |
Olivan Javier
Class A Common Stock
|
Chief Operating Officer | S Sale 5 lines combined | 1,575 | $707.20 wtd avg | $1.11M |
Since sale
$610.50 — -13.7% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-11-17 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
INTA |
HALL JOHN T
Common Stock
|
DirectorChief Executive Officer | S Sale 2 lines combined | 3,000 | $44.35 wtd avg | $133K |
Since sale
$43.72 — -1.4% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan date not disclosed |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
UTHR |
ROTHBLATT MARTINE A
Common Stock
|
DirectorChairperson & CEO | S Sale 19 lines combined | 9,500 | $543.32 wtd avg | $5.16M |
Since sale
$562.02 — +3.4% ▲
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-11-07 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
NET |
SEIFERT THOMAS J
Class A Common Stock
|
Chief Financial Officer | S Sale 7 lines combined | 12,500 | $299.59 wtd avg | $3.74M |
Since sale
$268.75 — -10.3% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-11-20 |
|
8
CEO/CFO sale+8
Routine8
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
GWRE |
Rosenbaum Michael George
Common Stock
|
DirectorChief Executive Officer | S Sale | 1,200 | $167.90 | $201K |
Since sale
$161.41 — -3.9% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-10-14 |
|
5
Unscheduled sale+5
Routine5
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
PAGS |
Magnani Alexandre Mr
Class A Common Shares
|
Director | S Sale | 16,209 | $11.18 wtd avg | $181K |
Since sale
$7.60 — -32.0% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Unscheduled |
|
5
Unscheduled sale+5
Routine5
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
HSY |
HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL
Common Stock, $1.00 par value
|
10% owner | S Sale 4 lines combined | 10,000 | $167.48 wtd avg | $1.67M |
Since sale
$178.08 — +6.3% ▲
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Unscheduled |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CVX |
Pate R. Hewitt
Common Stock
|
Chief Legal Officer | S Sale | 2,400 | $225.61 | $541K |
Since sale
$212.65 — -5.7% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2025-11-26 |
|
4
Officer sale+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
CSTL |
MAETZOLD DEREK J
Common Stock
|
DirectorPres. & Chief Exec. Officer | S Sale 3 lines combined | 14,496 | $31.91 wtd avg | $463K |
Since sale
$32.52 — +1.9% ▲
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2026-06-02 |
|
4
3 insiders selling within 30d+4
Routine4
Measures how rare and deliberate this trade is — not expected return. Tested against post-filing returns (median 113-day hold): the bands showed no short-horizon edge. Longer horizons untested.
|
VCYT |
Bhanji Muna
Common Stock
|
Director | S Sale | 1,864 | $43.70 | $81K |
Since sale
$24.16 — -44.7% ▼
vs SPY -0.7%
18 days held · as of Nov 6
|
2026-10-19 | Scheduled plan adopted 2026-06-02 |